Polypill in Acute Coronary Syndrome
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 140 participants.
Also called NCT05514938
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 140 participants
- Registry
-
NCT05514938
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT05514938. Randomized; no masking; primary purpose treatment. Start 2022-11-30 (actual); primary completion 2025-05-30 (actual). Results posted on 2026-05-14.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Polypill in Acute Coronary Syndrome
- Acronym
- POLY-ACS
- Condition
- Acute Coronary Syndrome
- Condition
- Lipid Disorder
- Condition
- Coronary Artery Disease
- Intervention (Drug)
- Polypill
- Intervention (Drug)
- Usual Care (individual medications prescribed by primary cardiologist)
- Lead sponsor
- University of Texas Southwestern Medical Center
Record details
- Record id
cardio:ct-nct05514938- Content hash
05306b953d284c0a0594be47e67cb778469e52942578494d8415a61f9a291776